Cleared Abbreviated

K202293 - Radiographic System Challenge X

K202293 is the FDA 510(k) clearance for Radiographic System Challenge X by Sedecal., Sa.. It is a Class 2 Radiology device (product code KPR) cleared through the Abbreviated 510(k) pathway after a 55-day FDA review.

K202293 · Sedecal., Sa. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2020
Decision
55d
Days
Class 2
Risk

K202293 is an FDA 510(k) clearance for the Radiographic System Challenge X. Classified as System, X-ray, Stationary (product code KPR), Class II - Special Controls.

Submitted by Sedecal., Sa. (Algete, ES). The FDA issued a Cleared decision on October 7, 2020 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1680 - the FDA radiology and imaging software oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Sedecal., Sa. devices

Submission Details

510(k) Number K202293 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 2020
Decision Date October 07, 2020
Days to Decision 55 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 107d · This submission: 55d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code KPR System, X-ray, Stationary
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Kamm & Associates
Daniel Kamm

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - KPR System, X-ray, Stationary

All 164
Devices cleared under the same product code (KPR) and FDA review panel - the closest regulatory comparables to K202293.
Apolo D / Apolo S
K202388 · Vmi Tecnologias Ltda · Dec 2020
MiniCAT 2D
K201825 · Xoran Technologies, LLC · Nov 2020
YSIO X.pree
K201670 · Siemens Medical Solutions USA, Inc. · Oct 2020
GXR-Series Diagnostic X-Ray System
K202572 · DRGEM Corporation · Sep 2020
EOSedge
K202394 · Eos Imaging · Sep 2020
DIAMOND-5A/6A/8A
K202156 · DRGEM Corporation · Sep 2020